Zinc-metallothionein: A potential mediator of antioxidant defence mechanisms in response to dopamine-induced stress

Canadian Journal of Physiology and Pharmacology

Volumn 88, Issue 3, 2010, Pages 305-312

  Eibl, Joseph K ^a   Abdallah, Zouleika ^b   Ross, Gregory M ^b  

^a LAURENTIAN UNIVERSITY   (Canada)

^b NORTHERN ONTARIO SCHOOL OF MEDICINE   (Canada)

Author keywords

Antioxidant; Arylation; Dopamine; MT; Neurotoxicity; Parkinson's disease; Zinc

Indexed keywords

DOPAMINE; METALLOTHIONEIN; NEUROTOXIN; ZINC;

ANTIOXIDANT ACTIVITY; DOPAMINERGIC NERVE CELL; HUMAN; MOBILIZATION; MOLECULAR SENSOR; NEUROTOXICITY; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; STRESS;

AMINO ACID SEQUENCE; ANIMALS; ANTIOXIDANTS; DOPAMINE; HUMANS; METALLOTHIONEIN; MOLECULAR SEQUENCE DATA; OXIDATIVE STRESS; PARKINSON DISEASE; PROTEIN STRUCTURE, TERTIARY; SIGNAL TRANSDUCTION;

EID: 77950868789     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/Y10-022     Document Type: Review

References (37)

1. Aoyama, K., Watabe, M., and Nakaki, T. 2008. Regulation of neu-ronal glutathione synthesis. J. Pharmacol. Sci. 108(3): 227-238. doi:10.1254/jphs. 08R01CR. PMID: 19008644.
2. Asanuma, M., Miyazaki, I., Diaz-Corrales, F.J., and Ogawa, N. 2004. Quinone formation as dopaminergic neuron-specific oxi-dative stress in the pathogenesis of sporadic Parkinson's disease and neurotoxin-induced parkinsonism. Acta Med. Okayama, 58(5): 221-233. PMID: 15666991.
3. Bozzi, Y., and Borrelli, E. 2006. Dopamine in neurotoxicity and neuroprotection: what do D2 receptors have to do with it? Trends Neurosci. 29(3): 167-174. doi:10.1016/j.tins.2006.01. 002. PMID: 16443286.
4. Braun, W., Vasák, M., Robbins, A.H., Stout, C.D., Wagner, G., Kägi, J.H., and Wüthrich, K. 1992. Comparison of the NMR solution structure and the X-ray crystal structure of rat metallothio-nein-2. Proc. Natl. Acad. Sci. U.S.A. 89(21): 10124-10128. doi:10.1073/pnas.89.21.10124. PMID: 1438200.
5. Chae, S.W., Bang, Y.J., Kim, K.M., Lee, K.Y., Kang, B.Y., Kim, E.M., et al. 2007. Role of cyclooxygenase-2 in tetrahydrobiop-terin-induced dopamine oxidation. Biochem. Biophys. Res. Commun. 359(3): 735-741. doi:10.1016/j.bbrc. 2007.05.190. PMID: 17560944.
6. Cho, Y., Gorina, S., Jeffrey, P.D., and Pavletich, N.P. 1994. Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. Science, 265(5170): 346-355. doi:10.1126/science.8023157. PMID: 8023157.
7. Chung, R.S., Hidalgo, J., and West, A.K. 2008a. New insight into the molecular pathways of metallothionein-mediated neuropro-tection and regeneration. J. Neurochem. 104(1): 14-20. PMID: 17986229.
8. Chung, R.S., Penkowa, M., Dittmann, J., King, C.E., Bartlett, C., Asmussen, J.W., et al. 2008b. Redefining the role of metal-lothionein within the injured brain: extracellular metallothio-neins play an important role in the astrocyte-neuron response to injury. J. Biol. Chem. 283(22): 15349-15358. doi:10.1074/jbc. M708446200. PMID: 18334482.
9. Cousins, R.J., Liuzzi, J.P., and Lichten, L.A. 2006. Mammalian zinc transport, trafficking, and signals. J. Biol. Chem. 281(34): 24085-24089. doi:10.1074/jbc.R600011200. PMID: 16793761.
10. Dagher, A., and Robbins, T.W. 2009. Personality, addiction, dopa-mine: insights from Parkinson's disease. Neuron, 61(4): 502-510. doi:10.1016/j.neuron. 2009.01.031. PMID: 19249271.
11. Davison, A.J., and Gee, P. 1984. Redox state of cytochrome c in the presence of the 6-hydroxydopamine/oxygen couple: oscillations dependent on the presence of hydrogen peroxide or super-oxide. Arch. Biochem. Biophys. 233(2): 761-771. doi:10.1016/0003-9861(84)90504-90506 PMID: 6091557.
12. Dinkova-Kostova, A.T., Holtzclaw, W.D., and Wakabayashi, N. 2005. Keap1, the sensor for electrophiles and oxidants that regulates the phase 2 response, is a zinc metalloprotein. Biochemistry, 44(18): 6889-6899. doi:10.1021/ bi047434h. PMID: 15865434.
13. Fattman, C.L., Schaefer, L.M., and Oury, T.D. 2003. Extracellular superoxide dismutase in biology and medicine. Free Radic. Biol. Med. 35(3): 236-256. doi:10.1016/S0891-5849(03)00275-2. PMID: 12885586.
14. Foppoli, C., Coccia, R., Cini, C., and Rosei, M.A. 1997. Catechola-mines oxidation by xanthine oxidase. Biochim. Biophys. Acta, 1334(2-3): 200-206. PMID: 9101714.
15. Frederickson, C. 2003. Imaging zinc: old and new tools. Sci. STKE, 2003(182): pe18. doi:10.1126/stke.2003.182.pe18. PMID: 12746547.
16. Frederickson, C.J., Koh, J.Y., and Bush, A.I. 2005. The neurobiol-ogy of zinc in health and disease. Nat. Rev. Neurosci. 6(6): 449-462. doi:10.1038/nrn1671. PMID: 15891778.
17. Gauthier, M.A., Eibl, J.K., Crispo, J.A., and Ross, G.M. 2008. Covalent arylation of metallothionein by oxidized dopamine products: a possible mechanism for zinc-mediated enhancement of dopaminergic neuron survival. Neurotox. Res. 14(4): 317-328. doi:10.1007/BF03033856. PMID: 19073435.
18. Graham, D.G., Tiffany, S.M., Bell, W.R., Jr., and Gutknecht, W.F. 1978. Autoxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine, and related compounds toward C1300 neuroblastoma cells in vitro. Mol. Pharmacol. 14(4): 644-653. PMID: 567274.
19. Hastings, T.G. 1995. Enzymatic oxidation of dopamine: the role of prostaglandin H synthase. J. Neurochem. 64(2): 919-924. PMID: 7830086.
20. Hastings, T.G., Lewis, D.A., and Zigmond, M.J. 1996. Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections. Proc. Natl. Acad. Sci. U.S.A. 93(5): 1956-1961. doi:10. 1073/pnas.93.5.1956. PMID: 8700866.
21. Hattoria, N., Wanga, M., Taka, H., Fujimura, T., Yoritaka, A., Kubo, S., and Mochizuki, H. 2009. Toxic effects of dopamine metabolism in Parkinson's disease. Parkinsonism Relat. Disord. 15(Suppl 1): S35-S38. doi:10.1016/S1353- 8020(09)70010-0. PMID: 19131041.
22. Heikkila, R.E., and Cohen, G. 1973. 6-Hydroxydopamine: evidence for superoxide radical as an oxidative intermediate. Science, 181(98): 456-457. doi:10.1126/science.181.4098.456. PMID: 4718113.
23. Huang, Y.Z., Pan, E., Xiong, Z.Q., and McNamara, J.O. 2008. Zinc-mediated transactivation of TrkB potentiates the hippocam-pal mossy fiber-CA3 pyramid synapse. Neuron, 57(4): 546-558. doi:10.1016/j.neuron.2007.11.026. PMID: 18304484.
24. Korytowski, W., Sarna, T., Kalyanaraman, B., and Sealy, R.C. 1987. Tyrosinase-catalyzed oxidation of dopa and related cate-chol(amine)s: a kinetic electron spin resonance investigation using spin-stabilization and spin label oximetry. Biochim. Bio-phys. Acta, 924(3): 383-392. PMID: 3036239.
25. LaVoie, M.J., Ostaszewski, B.L., Weihofen, A., Schlossmacher, M.G., and Selkoe, D.J. 2005. Dopamine covalently modifies and functionally inactivates parkin. Nat. Med. 11(11): 1214-1221. doi:10.1038/nm1314. PMID: 16227987.
26. Lichtlen, P., Wang, Y., Belser, T., Georgiev, O., Certa, U., Sack, R., and Schaffner, W. 2001. Target gene search for the metal-responsive transcription factor MTF-1. Nucleic Acids Res. 29(7): 1514-1523. doi:10.1093/nar/29.7.1514. PMID: 11266553.
27. Maret, W. 2006. Zinc coordination environments in proteins as re-dox sensors and signal transducers. Antioxid. Redox Signal. 8(9-10): 1419-1441. doi:10.1089/ars.2006.8.1419. PMID: 16987000.
28. Maret, W., and Vallee, B.L. 1998. Thiolate ligands in metallothio-nein confer redox activity on zinc clusters. Proc. Natl. Acad. Sci. U.S.A. 95(7): 3478-3482. doi:10.1073/pnas.95.7.3478. PMID: 9520391.
29. Miyazaki, I., and Asanuma, M. 2008. Dopaminergic neuron-specific oxidative stress caused by dopamine itself. Acta Med. Okayama, 62(3): 141-150. PMID: 18596830.
30. Miyazaki, I., Asanuma, M., Hozumi, H., Miyoshi, K., and Sogawa, N. 2007. Protective effects of metallothionein against dopamine quinone-induced dopaminergic neurotoxicity. FEBS Lett. 581(25): 5003-5008. doi:10.1016/j. febslet.2007.09.046. PMID: 17910954.
31. Rabinovic, A.D., and Hastings, T.G. 1998. Role of endogenous glu-tathione in the oxidation of dopamine. J. Neurochem. 71(5): 2071-2078. PMID: 9798932.
32. Robinson, D.L., Heien, M.L., and Wightman, R.M. 2002. Frequency of dopamine concentration transients increases in dorsal and ventral striatum of male rats during introduction of conspe-cifics. J. Neurosci. 22(23): 10477-10486. PMID: 12451147.
33. Ross, G.M., McCarry, B.E., Thakur, S., and Mishra, R.K. 1993. Identification of novel catecholamine absorbing proteins in the central nervous system. J. Mol. Neurosci. 4(3): 141-148. doi:10. 1007/BF02782497. PMID: 8292487.
34. Smith, A.D., and Justice, J.B. 1994. The effect of inhibition of synthesis, release, metabolism and uptake on the microdialysis extraction fraction of dopamine. J. Neurosci. Methods, 54(1): 75-82. doi:10.1016/0165- 0270(94)90161-9. PMID: 7815821.
35. West, A.K., Hidalgo, J., Eddins, D., Levin, E.D., and Aschner, M. 2008. Metallothionein in the central nervous system: roles in protection, regeneration and cognition. Neurotoxicology, 29(3): 489-503. doi:10.1016/j.neuro.2007.12. 006. PMID: 18313142.
36. Whitehead, R.E., Ferrer, J.V., Javitch, J.A., and Justice, J.B. 2001. Reaction of oxidized dopamine with endogenous cysteine residues in the human dopamine transporter. J. Neurochem. 76(4): 1242-1251. doi:10.1046/j.1471-4159. 2001.00125.x. PMID: 11181843.
37. Zelko, I.N., Mariani, T.J., and Folz, R.J. 2002. Superoxide dismu-tase multigene family: a comparison of the CuZn-SOD (SOD1), Mn-SOD (SOD2), and EC-SOD (SOD3) gene structures, evolution, and expression. Free Radic. Biol. Med. 33(3): 337-349. doi:10.1016/S0891-5849(02)00905-X. PMID: 12126755.